Clinical features and outcomes of patients with hepatocellular carcinoma complicated with bile duct invasion
Open Access
- 25 June 2017
- journal article
- Published by The Korean Association for the Study of the Liver in Clinical and Molecular Hepatology
- Vol. 23 (2) , 160-169
Abstract
Little is known about the treatment or outcomes of hepatocellular carcinoma (HCC) complicated with bile duct invasion. A total of 247 consecutive HCC patients with bile duct invasion at initial diagnosis were retrospectively included. The majority of patients had Barcelona Clinic Liver Cancer (BCLC) stage C HCC (66.8%). Portal vein tumor thrombosis was present in 166 (67.2%) patients. Median survival was 4.1 months. Various modalities of treatment were initially employed including surgical resection (10.9%), repeated transarterial chemoembolization (TACE) (42.5%), and conservative management (42.9%). Among the patients with obstructive jaundice (n=88), successful biliary drainage was associated with better overall survival rate. Among the patients with BCLC stage C, overall survival differed depending on the initial treatment for HCC; surgical resection, TACE, systemic chemotherapy, and conservative management showed overall survival rates of 11.5, 6.0 ,2.4, and 1.6 months, respectively. After adjusting for confounders, surgical resection and repeated TACE were significant prognostic factors for HCC patients with bile duct invasion (hazard ratios 0.47 and 0.39, Ps <0.001, respectively). The survival of HCC patients with bile duct invasion at initial diagnosis is generally poor. However, aggressive treatments for HCC such as resection or biliary drainage may be beneficial therapeutic options for patients with preserved liver function.Keywords
This publication has 34 references indexed in Scilit:
- Management of Hepatocellular Carcinoma: An Update ΔσHepatology, 2011
- Surgical outcome of hepatocellular carcinoma patients with biliary tumor thrombiWorld Journal of Surgical Oncology, 2011
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Clinicopathological Characteristics of 20 Cases of Hepatocellular Carcinoma with Bile Duct Tumor ThrombiDigestive Diseases and Sciences, 2010
- Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasionJournal of Gastroenterology and Hepatology, 2009
- Staging of Hepatocellular CarcinomaAnnals of Surgery, 2007
- A comparison of covered and uncovered Wallstents for the management of distal malignant biliary obstructionGastrointestinal Endoscopy, 2006
- Obstructive jaundice secondary to hepatocellular carcinomaSurgical Oncology, 1995
- Obstructive jaundice secondary to ruptured hepatocellular carcinoma into the common bile duct. Surgical experiences of 20 casesCancer, 1994
- Hepatocellular carcinoma presenting as intrabile duct tumor growth. A clinicopathologic study of 24 casesCancer, 1982